For decades, prostate cancer treatment has largely been described by where the cancer is located and how far it has spread. Today, physicians can also look at something much more specific: what is happening on the surface of the cancer cell itself. One important target is PSMA, or prostate-specific membrane antigen. PSMA is a protein […]
Pluvicto and PSMA-Targeted Therapy: A New Era in Prostate Cancer Care Read More »
Alzheimer’s treatment is changing. With the introduction of newer anti-amyloid therapies, patients and families have more treatment options to discuss with their physicians—but these therapies also come with important monitoring requirements. One of the most important is MRI monitoring for Amyloid-Related Imaging Abnormalities, or ARIA. ARIA can occur in patients receiving certain amyloid-targeting therapies for
ARIA MRI Monitoring at Excel: Why MRI Matters During Alzheimer’s Treatment Read More »
As Alzheimer’s disease care continues to evolve, advanced imaging technologies are becoming increasingly important in helping physicians diagnose, monitor, and guide treatment decisions with greater confidence. One of the latest innovations supporting this process is AI-assisted MRI analysis, designed to provide objective insights into brain changes associated with dementia and anti-amyloid therapies. At Excel Diagnostics
WILMETTE, Ill. and HOUSTON, Texas, June 11, 2025 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar,” the “Company,” “us” and “our”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, in collaboration with Excel Diagnostics and Nuclear Oncology Center (“EDNOC”), a premier diagnostic medical imaging and therapeutic nuclear
A Day of Hope and Unity: Our Team at the ZERO Prostate Cancer Run/Walk On September 7th, our team from the Diagnostics & Nuclear Oncology Center had the honor of participating in the ZERO Prostate Cancer Run/Walk at MacGregor Park in Houston, Texas. It was a day filled with hope, camaraderie, and a shared commitment
ZERO Prostate Cancer Run/Walk Read More »
About 20 million Americans currently have some form of thyroid disease. If you’re one of those 20 million people, you might be wondering how nuclear medicine 一 particularly radioisotope therapy 一 can play a crucial role in diagnosis and treatment. The answer lies in the powerful capabilities of nuclear medicine techniques used here at Excel Diagnostics & Nuclear Oncology Center. Here’s how
Thyroid Disease: How Nuclear Medicine Can Help Read More »
What are neuroendocrine tumors (NETs)? Neuroendocrine tumors (NETs) are a group of rare tumors that originate in neuroendocrine cells. These tumors can also be referred to as neuroendocrine neoplasms (NENs) or neuroendocrine carcinomas (NECs). Depending on the type of cell in which the cancer originates, there are various types of NETs. In most cases, NETs grow
World NET Cancer Day Read More »
With the exception of skin cancer, prostate cancer is the most prevalent form of cancer in men. It affects 13 out of every 100 men, according to the Centers for Disease Control and Prevention (CDC). Out of the 13% of men who are diagnosed with prostate cancer, an estimated 2-3 die from it. These statistics highlight the importance
How Is Prostate Cancer Diagnosed and Treated? Read More »
What is Alzheimer? Alzheimer can be detected and treated if possible. When detected at an early stage in active patients, any intervention that slows down the advancement of the condition holds the promise of extending a person’s productive life and postponing the onset of dementia. Provides access to a pathway of care, including enrollment in
Act Early with New Diagnostic Imaging for Alzheimer! Read More »
